Caribou Biosciences Inc (CRBU) Stock Price, Quote & News

Company Profile

Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies. The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Ho...

Industry: Biotechnology

Sector: Healthcare

Phone: 510 982 6030

Website: cariboubio.com

Address:

2929 7th Street, Suite 105, Berkeley, United States

Jidane Jul. 14 at 10:11 PM

$CRBU Obviously, volumes are really heavy over the past two weeks. Is it because of the addition to indices? Any idea?

0 · Reply

cta7978 Jul. 14 at 7:44 PM

$CRBU Pfizer

0 · Reply

cta7978 Jul. 14 at 7:40 PM

$CRBU Let's get a financing deal.

0 · Reply

ChicagoJoe20 Jul. 14 at 4:03 PM

$CRBU cue the pfizer pun

1 · Reply

Jidane Jul. 14 at 1:44 PM

$CRBU Seeing today’s CPI number, This is the beginning of the deflation, not the opposite.

0 · Reply

HughGeez Jul. 13 at 9:01 PM

$CRBU Well, that bounced like a wet sponge. No problem. In for the long run!

1 · Reply

ETAlpha Jul. 13 at 3:44 PM

$AGEN Falling wedge Needs close back above wedge (7-7.1) Big level here at VWAP 5 minute close needed over wedge for entries IMO otherwise NO ENTRY For more action in the biotech and immuno-oncology space, keep an eye on related tickers $CRBU (Caribou Biosciences) and $GILD (Gilead Sciences). Price always speaks first. I'll post the chart when the signal is confirmed. Check out my homepage for more information!

0 · Reply

HughGeez Jul. 13 at 2:59 PM

$CRBU I don't want to post a sad caribou picture. Let's go CRBU, bounce please!

1 · Reply

Windytimes Jul. 13 at 1:42 PM

$CRBU $PRME $BEAM $NTLA $CRSP MADDENING!!!!

1 · Reply

RocroBio Jul. 13 at 6:52 AM

$CRBU patience is a virtue (especially in sbic micros)

1 · Reply

Caribou Biosciences Transcript: H.C. Wainwright 4th Annual Cell Therapy Virtual Conference

Jun 29, 2026, 8:00 AM EDT - 16 days ago

Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference

Jun 17, 2026, 10:30 AM EDT - 27 days ago

Caribou Biosciences Transcript: AGM 2026

2026-06-11T13:03:22.000Z - 4 weeks ago

Caribou Biosciences presents ANTLER trial results at EHA

Jun 11, 2026, 8:01 AM EDT - 4 weeks ago

Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026

Jun 11, 2026, 8:00 AM EDT - 4 weeks ago

Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting

Jun 10, 2026, 7:00 AM EDT - 5 weeks ago

Caribou Biosciences Slides: Corporate presentation

Jun 5, 2026, 8:00 AM EDT - 5 weeks ago

Caribou Biosciences Proxy statement: Proxy filing

Jun 4, 2026, 2:35 PM EDT - 5 weeks ago

Caribou Biosciences Transcript: Jefferies Global Healthcare Conference 2026

May 27, 2026, 4:05 PM EDT - 6 weeks ago

Caribou Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference

May 19, 2026, 12:30 PM EDT - 2 months ago

Caribou Biosciences Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference

May 13, 2026, 4:05 PM EDT - 2 months ago

Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference

May 13, 2026, 11:40 AM EDT - 2 months ago

Caribou Biosciences Transcript: Bank of America Global Healthcare Conference 2026

May 12, 2026, 9:30 AM EDT - 2 months ago

Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting

2026-05-11T10:25:24.000Z - 2 months ago

Caribou Biosciences price target raised to $11 from $9 at H.C. Wainwright

May 7, 2026, 4:05 PM EDT - 2 months ago

Caribou Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update

May 7, 2026, 7:00 AM EDT - 2 months ago

Caribou Biosciences Quarterly report: Q1 2026

May 7, 2026, 7:00 AM EDT - 2 months ago

Caribou Biosciences Earnings release: Q1 2026

May 5, 2026, 4:05 PM EDT - 2 months ago

Caribou Biosciences to Participate in the BofA Securities 2026 Health Care Conference

May 1, 2026, 8:00 AM EDT - 2 months ago

Caribou Biosciences Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 2 months ago

Caribou Biosciences Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 2 months ago

Caribou Biosciences Proxy statement: Proxy filing

Apr 10, 2026, 8:00 AM EDT - 3 months ago

Caribou Biosciences Proxy statement: Proxy filing

Mar 31, 2026, 8:00 AM EDT - 3 months ago

Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy

Mar 10, 2026, 8:00 AM EDT - 4 months ago

Caribou Biosciences Transcript: Leerink Global Healthcare Conference 2026

2026-03-09T12:14:17.000Z - 4 months ago

Caribou Biosciences price target raised to $13 from $11 at Evercore ISI

2026-03-05T21:28:29.000Z - 4 months ago

Caribou Biosciences reports Q4 EPS (28c) vs. (39c) last year

Mar 5, 2026, 4:05 PM EST - 4 months ago

Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Mar 5, 2026, 3:00 PM EST - 4 months ago

Caribou Biosciences Annual report: Q4 2025

Mar 5, 2026, 3:00 PM EST - 4 months ago

Caribou Biosciences Earnings release: Q4 2025

Feb 19, 2026, 10:45 AM EST - 5 months ago

Caribou Biosciences Transcript: Citi’s 2026 Virtual Oncology Leadership Summit

Feb 17, 2026, 8:00 AM EST - 5 months ago

Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample

Feb 12, 2026, 4:05 PM EST - 5 months ago

Caribou Biosciences to Participate in Upcoming Investor Conferences

Feb 4, 2026, 8:00 AM EST - 5 months ago

Caribou Biosciences Announces Late-Breaking Presentations at the 2026 Tandem Meetings of ASTCT® and CIBMTR®

2026-02-02T21:25:29.000Z - 5 months ago

Caribou Biosciences initiated with a Buy at Clear Street

2026-01-06T15:15:25.000Z - 6 months ago

Caribou Biosciences price target lowered to $6 from $8 at BofA

Dec 6, 2025, 7:30 AM EST - 7 months ago

Caribou Biosciences Transcript: The 67th American Society of Hematology (ASH) Annual Meeting

Dec 3, 2025, 7:00 AM EST - 8 months ago

Caribou Biosciences Slides: Corporate Presentation

Dec 2, 2025, 8:45 AM EST - 8 months ago

Caribou Biosciences Transcript: Evercore ISI 8th Annual HealthCONx Conference

Dec 1, 2025, 4:05 PM EST - 8 months ago

Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025

2025-11-12T22:25:13.000Z - 8 months ago

Caribou Biosciences reports Q3 EPS (30c) vs. (38c) last year

Nov 12, 2025, 4:05 PM EST - 8 months ago

Caribou Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 12, 2025, 7:00 AM EST - 8 months ago

Caribou Biosciences Earnings release: Q3 2025

Nov 12, 2025, 7:00 AM EST - 8 months ago

Caribou Biosciences Quarterly report: Q3 2025

2025-11-05T11:21:02.000Z - 9 months ago

Caribou Biosciences price target raised to $9 from $3 at H.C. Wainwright

2025-11-03T15:15:34.000Z - 9 months ago

Caribou Biosciences price target raised to $8 from $5 at Citi

Nov 3, 2025, 8:00 AM EST - 9 months ago

Caribou Biosciences Transcript: Study Result

Nov 3, 2025, 8:00 AM EST - 9 months ago

Caribou Biosciences Press release: Study Result

Nov 3, 2025, 8:00 AM EST - 9 months ago

Caribou Biosciences Slides: Study Result

2025-11-03T12:22:51.000Z - 9 months ago

Caribou Biosciences announces results from CaMMouflage Phase 1 trial

2025-11-03T12:15:12.000Z - 9 months ago

Caribou Biosciences announces results from ANTLER phase 1 trial of vispa-cel

Nov 3, 2025, 7:00 AM EST - 9 months ago

Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma

Nov 3, 2025, 7:00 AM EST - 9 months ago

Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies

Nov 2, 2025, 4:00 PM EST - 9 months ago

Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma

Caribou Biosciences Transcript: Citi's Biopharma Back to School Conference

Sep 3, 2025, 2:30 PM EDT - 11 months ago

0 · Reply

cta7978 Jul. 14 at 7:44 PM

$CRBU Pfizer

0 · Reply

cta7978 Jul. 14 at 7:40 PM

$CRBU Let's get a financing deal.

0 · Reply

ChicagoJoe20 Jul. 14 at 4:03 PM

$CRBU cue the pfizer pun

1 · Reply

Jidane Jul. 14 at 1:44 PM

$CRBU Seeing today’s CPI number, This is the beginning of the deflation, not the opposite.

0 · Reply

HughGeez Jul. 13 at 9:01 PM

$CRBU Well, that bounced like a wet sponge. No problem. In for the long run!

1 · Reply

ETAlpha Jul. 13 at 3:44 PM

0 · Reply

HughGeez Jul. 13 at 2:59 PM

$CRBU I don't want to post a sad caribou picture. Let's go CRBU, bounce please!

1 · Reply

Windytimes Jul. 13 at 1:42 PM

$CRBU $PRME $BEAM $NTLA $CRSP MADDENING!!!!

1 · Reply

RocroBio Jul. 13 at 6:52 AM

$CRBU patience is a virtue (especially in sbic micros)

1 · Reply

josegodoy Jul. 11 at 6:20 PM

$CRBU Chart: simple line (weekly) - this coming week (looking like) it’s gonna be hot

0 · Reply

deaccord Jul. 10 at 8:23 PM

$CRBU More than average volume, more buyers stepped up to take the cheap shares

0 · Reply

dibatista Jul. 10 at 8:00 PM

$CRBU beautiful recovery🔥🔥

0 · Reply

Brandonswest Jul. 10 at 7:41 PM

$CRBU little bit of late life here. As it should be. Looks alot like $CMPX today.

0 · Reply

HughGeez Jul. 10 at 5:30 PM

$CRBU Hopefully better days ahead

1 · Reply

ChicagoJoe20 Jul. 10 at 5:29 PM

$CRBU 🧐

0 · Reply

deaccord Jul. 10 at 5:04 PM

$CRBU Very suspicious price movement, I bought more on this dip

0 · Reply

Jidane Jul. 10 at 3:46 PM

$CRBU We’re not new to this, but ha. XBI have gone up 20% and down.

0 · Reply

cta7978 Jul. 10 at 3:39 PM

$CRBU

0 · Reply

deaccord Jul. 9 at 6:58 PM

$CRBU Buyers stepback to hopefully buy more cheap sharee

0 · Reply

HughGeez Jul. 9 at 3:39 AM

$CRBU today

0 · Reply

boolfool Jul. 8 at 9:50 PM

$CRBU I bought this in May 2025 with original cost of .75/share. I thought for sure it would be at $5 or bought out by now. Will continue to hold but I’m getting bored.

2 · Reply

Market Cap	178.53M
Revenue (ttm)	11.16M
Net Income (ttm)	-148.13M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,327.33%
Debt to Equity Ratio	0.00

Volume	3,961,100
Avg Vol	2,182,388
Day's Range	N/A - N/A
Shares Out	99.18M
Stochastic %K	6%
Beta	2.36
Analysts	Strong Sell
Price Target	$12.00